Non Applicability of Annual Secretarial Compliance Certificate for the year ended 31st March, 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Ishita Drugs & Industries Ltd has informed the BSE that it is not required to file the Annual Secretarial Compliance Report under SEBI Regulation 24A for the financial year ended 31st March 2025. The company qualifies for exemption under Regulation 15(2) of the SEBI Listing Obligations and Disclosure Requirements (LODR) Regulations, 2015, because its paid-up equity share capital is below Rs. 10 crore and its net worth is below Rs. 25 crore as on the last day of the previous financial year. This exemption was clarified by a BSE circular dated 14th May 2019. The disclosure has been signed by Managing Director Jagdish Agrawal.
This is a routine procedural filing with no material impact on shareholders or the stock price. It simply confirms that the company is small enough to qualify for reduced compliance requirements available to small-cap listed entities.